The management of several cardiac-related poisonings is updated in guidance from the American Heart Association (AHA). Focusing on the resuscitation of patients with cardiac arrest,
“Xylazine pharmacology, animal and human clinical effects, and what is known to date about care of patients experiencing acute overdose, xylazine–fentanyl withdrawal, and xylazine-associated wounds”
A threshold of 1.7 mg/kg of tetrahydrocannabinol (THC) in children younger than 6 years of age “may guide medical management and preventive regulations,” investigators conclude based
Death rates due to poisonings, firearms, and all other injuries increased substantially in the U.S. between 1999 and 2020, according to a cross-sectional study. National
FDA yesterday approved Emergent BioSolutions’ Narcan (naloxone hydrochloride) 4 mg nasal spray for OTC use. The action “paves the way for the life-saving medication to
FDA yesterday approved daprodustat tablets (Jesduvroq, GlaxoSmithKline) as the first oral treatment for anemia caused by chronic kidney disease for adults who have been receiving
Fentanyl and psychostimulants were responsible for much of an 81% increase in fatal overdoses among pregnant and postpartum Americans in 2017–20, a study shows. “Although
Healthcare professionals should be cautious of possible xylazine inclusion in fentanyl, heroin, and other illicit drug overdoses, as naloxone may not be able to reverse
In the current issue of the New England Journal of Medicine are 3 multimedia presentations of interest: The development of new COVID-19 vaccines is discussed